首页> 外国专利> Process for the preparation of(1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate

Process for the preparation of(1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate

机译:(1S,2R)-1-氨基-2-茚满醇-(R,R)-酒石酸甲醇溶剂化物的制备方法

摘要

Process for the preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate, in which in a solvent a mixture of enantiomers of cis-1-amino-2-indanol reacts at an elevated temperature with (R,R)-tartaric acid and methanol and in which optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate crystallizes out, after which the crystals are recovered, the recovery taking place at a temperature between 10 and 50 DEG C in the presence of 0-20 wt.% water relative to the amount of methanol plus solvent, on the understanding that if the reaction mixture is essentially free from water the recovery substantially takes place at a temperature between 30 and 50 DEG C. Preferably the reactants are at least in part contacted with each other at an elevated temperature and only methanol is used as solvent. Preferably the amount of (1S,2R)-1-amino-2-indanol applied is between 0.02 and 0.1 g per ml of solvent. The invention also relates to (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate crystals having a particle size larger than 95 mu m, expressed as DÄv, 0.9Ü, in particular those in which the enantiomeric excess of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate relative to (1R,2S)-1-amino-2-indanol-(R,R)-tartrate is higher than 96%, as well as to application of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate in the preparation of AIDS inhibitors, in particular indinavir sulphate.
机译:(1S,2R)-1-氨基-2-茚满醇-(R,R)-酒石酸甲醇溶剂化物的制备方法,其中在溶剂中顺式-1-氨基-2-茚满醇的对映异构体混合物在(R,R)-酒石酸和甲醇在升高的温度下结晶,其中光学富集(1S,2R)-1-氨基-2-茚满醇-(R,R)-酒石酸甲醇溶剂化物,然后结晶回收,在相对于甲醇加溶剂的量为0-20重量%的水存在下,在10至50℃的温度下进行回收,要理解的是如果反应混合物基本上不含水,则回收基本上在30至50℃之间的温度下进行。优选地,反应物在升高的温度下至少部分地彼此接触,并且仅甲醇用作溶剂。优选地,(1S,2R)-1-氨基-2-茚满醇的用量为每毫升溶剂0.02至0.1克。本发明还涉及(1S,2R)-1-氨基-2-茚满醇-(R,R)-酒石酸甲醇溶剂化物晶体,其具有大于95μm的粒径,表示为DÄv,0.9Ü,特别是那些(1S,2R)-1-氨基-2-茚满醇-(R,R)-酒石酸酯相对于(1R,2S)-1-氨基-2-茚满醇-(R,R)-酒石酸酯的对映体过量为高于96%,以及(1S,2R)-1-氨基-2-茚满醇-(R,R)-酒石酸甲醇溶剂化物在制备AIDS抑制剂,特别是茚地那韦硫酸盐中的应用。

著录项

  • 公开/公告号EP0890571B1

    专利类型

  • 公开/公告日2002-01-30

    原文格式PDF

  • 申请/专利权人 DSM N.V.;

    申请/专利号EP19980201879

  • 发明设计人 HOF PATRICK ROBERT;

    申请日1998-06-05

  • 分类号C07C213/10;C07C215/44;

  • 国家 EP

  • 入库时间 2022-08-22 00:35:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号